Aquestive Therapeutics Readies for Key Investor Conferences
Aquestive Therapeutics to Engage Investors in September
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a leading pharmaceutical entity focused on enhancing patient care through groundbreaking science and delivery systems, has announced its participation in a series of significant investor conferences this September. The management team is set to engage with investors, providing insights into their innovative approaches.
Conference Engagement Details
The schedule for these exciting events includes:
Cantor Healthcare Conference
Aquestive will be partaking in a fireside chat at 8:00 am ET on a Thursday, with opportunities for investor meetings available on the preceding day as well as on the day of the conference itself.
Wells Fargo Healthcare Conference
On September 5, the team will also be available to facilitate investor meetings, where they will discuss their strategic directions and ongoing projects.
H.C. Wainwright 26th Annual Global Investor Conference
Aquestive has a presentation scheduled for 10:00 am ET on Tuesday, where they will once again hold meetings for investors on the days surrounding the conference.
Webcasts and Presentations
For those unable to attend the conferences in person, a live webcast of the Cantor Healthcare Conference discussion and the subsequent H.C. Wainwright presentation can be accessed on Aquestive's website under the “Events and Presentation” section. There will also be a replay available for 30 days after the event, ensuring that potential and existing investors have ample opportunity to catch up on these discussions.
Overview of Aquestive Therapeutics
Aquestive Therapeutics is making strides in the pharmaceutical industry by focusing on technological innovations that aim to improve therapeutic delivery. The company excels in developing orally administered products that carry complex molecular structures, creating alternative solutions to the typically invasive standard of care therapies. Currently, Aquestive boasts four commercial products successfully marketed by their partners both in the U.S. and globally. They also specialize in collaborating with other pharmaceutical entities to introduce new molecules to the market, utilizing their proprietary technologies such as PharmFilm. Notably, they are progressing a late-stage product candidate targeting severe allergic reactions, including anaphylaxis, alongside a new topical gel designed for various dermatological applications.
Contact Information
For inquiries, you can reach out to:
Brian Korb
astr partners
brian.korb@astrpartners.com
Frequently Asked Questions
What events will Aquestive participate in during September?
Aquestive will attend the Cantor Healthcare Conference, Wells Fargo Healthcare Conference, and H.C. Wainwright Global Investor Conference.
How can investors access presentations from the events?
Investors can view presentations and live webcasts on the company's website and access replays for up to 30 days post-event.
What products does Aquestive currently market?
Aquestive's portfolio includes four commercial products that are delivered through partnerships around the globe.
What is the focus of Aquestive Therapeutics?
The company is focused on advancing medicines that enhance patient quality of life through innovative pharmaceutical delivery technologies.
Where can I find more information about Aquestive Therapeutics?
Additional information can be found by visiting the company’s website at Aquestive.com.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
